Anal cytology screening in men who have sex with men with HIV at a university hospital in Bogotá, Colombia.


Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 3 5 2022
medline: 14 6 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Risk of anal squamous cell carcinoma (anal cancer) is greater among men who have sex with men (MSM) living with human immunodeficiency virus (HIV). We describe the frequency of and factors associated with abnormal anal cytology results in Colombian MSM living with HIV. This retrospective observational cohort study included MSM ≥18 years old living with HIV screened with anal cytology at Hospital Universitario San Ignacio in Bogotá, Colombia between January 2019 and February 2020. A multivariable log-binomial regression model estimated associations with abnormal anal cytology. A total of 211 patients were included. Mean age was 35.6 years. Sixty-eight (32.3%) had an abnormal anal cytology result: ASC-US 33.8% ( These data provide crucial information to guide scale up of anal cancer screening at select centers in Colombia. Our results also suggest STI prevention efforts and improved virological control among MSM living with HIV may have the secondary benefit of reducing the risk of anal cancer.

Sections du résumé

BACKGROUND
Risk of anal squamous cell carcinoma (anal cancer) is greater among men who have sex with men (MSM) living with human immunodeficiency virus (HIV). We describe the frequency of and factors associated with abnormal anal cytology results in Colombian MSM living with HIV.
METHODS
This retrospective observational cohort study included MSM ≥18 years old living with HIV screened with anal cytology at Hospital Universitario San Ignacio in Bogotá, Colombia between January 2019 and February 2020. A multivariable log-binomial regression model estimated associations with abnormal anal cytology.
RESULTS
A total of 211 patients were included. Mean age was 35.6 years. Sixty-eight (32.3%) had an abnormal anal cytology result: ASC-US 33.8% (
CONCLUSIONS
These data provide crucial information to guide scale up of anal cancer screening at select centers in Colombia. Our results also suggest STI prevention efforts and improved virological control among MSM living with HIV may have the secondary benefit of reducing the risk of anal cancer.

Identifiants

pubmed: 35491739
doi: 10.1177/09564624221097742
pmc: PMC10430884
mid: NIHMS1900369
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-708

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH087222
Pays : United States

Références

Cancer Causes Control. 2019 Sep;30(9):989-996
pubmed: 31302838
Diagn Cytopathol. 2014 Oct;42(10):840-5
pubmed: 24591207
Dis Colon Rectum. 2008 Jul;51(7):1130-6
pubmed: 18481150
Ann Gastroenterol. 2019 May-Jun;32(3):257-263
pubmed: 31040622
Sex Transm Dis. 2011 Oct;38(10):964-9
pubmed: 21934574
J Community Health. 2018 Aug;43(4):792-801
pubmed: 29480339
PLoS One. 2018 Jul 5;13(7):e0199058
pubmed: 29975716
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Arq Gastroenterol. 2011 Apr-Jun;48(2):136-45
pubmed: 21709956
Sex Health. 2012 Dec;9(6):580-6
pubmed: 23380236
Clin Infect Dis. 2020 Jul 11;71(2):390-399
pubmed: 31504329
AIDS Behav. 2013 Mar;17(3):1129-36
pubmed: 22076229
PLoS One. 2015 Aug 07;10(8):e0131040
pubmed: 26252496
Cancer. 2004 Jul 15;101(2):270-80
pubmed: 15241823
Dis Colon Rectum. 2018 Jul;61(7):755-774
pubmed: 29878949
Dis Colon Rectum. 2019 Jan;62(1):112-120
pubmed: 30451747
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Infect Dis. 2016 Feb 1;213(3):351-60
pubmed: 26268855
AIDS Patient Care STDS. 2010 Sep;24(9):533-8
pubmed: 20731611
Clin Infect Dis. 2012 Apr;54(7):1026-34
pubmed: 22291097
Sex Transm Infect. 2019 Mar;95(2):122-128
pubmed: 30171173
J Surg Res. 2021 Nov;267:374-383
pubmed: 34216798
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):314-9
pubmed: 9525431

Auteurs

I Tatiana Ordoñez-Blanco (IT)

Departamento de Medicina Interna, Unidad de Infectología, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.
Facultad de Medicina, 89654Pontificia Universidad Javeriana, Bogotá, Colombia; Grupo de Investigación en Enfermedades Infecciosas, HUSI-PUJ.

Samuel Martínez-Vernaza (S)

Departamento de Medicina Interna, Unidad de Infectología, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.

Kevin J Blair (KJ)

Department of Surgery, 12222University of California Los Angeles (UCLA), Los Angeles, CA, USA.
South American Program in HIV Prevention Research (SAPHIR), Division of Infectious Diseases, Department of Medicine, 12222UCLA, Los Angeles, CA, USA.

Camilo Quiroga (C)

Departamento de Medicina Interna, Unidad de Infectología, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.
Facultad de Medicina, 89654Pontificia Universidad Javeriana, Bogotá, Colombia; Grupo de Investigación en Enfermedades Infecciosas, HUSI-PUJ.

Ellen Lowenstein (E)

Departamento de Medicina Interna, Unidad de Infectología, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.

Luis J Lombana Amaya (LJ)

Facultad de Medicina, 89654Pontificia Universidad Javeriana, Bogotá, Colombia; Grupo de Investigación en Enfermedades Infecciosas, HUSI-PUJ.
Departamento de Cirugía General, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.

Jesse Clark (J)

South American Program in HIV Prevention Research (SAPHIR), Division of Infectious Diseases, Department of Medicine, 12222UCLA, Los Angeles, CA, USA.

Jordan E Lake (JE)

South American Program in HIV Prevention Research (SAPHIR), Division of Infectious Diseases, Department of Medicine, 12222UCLA, Los Angeles, CA, USA.
McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX, USA.

Sandra Liliana Valderrama-Beltrán (SL)

Departamento de Medicina Interna, Unidad de Infectología, 173049Hospital Universitario San Ignacio, Bogotá, Colombia.
Facultad de Medicina, 89654Pontificia Universidad Javeriana, Bogotá, Colombia; Grupo de Investigación en Enfermedades Infecciosas, HUSI-PUJ.
Programa de doctorado en epidemiología, Departamento de Epidemiología Clínica y Bioestadística, Pontificia Universidad Javeriana, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH